Bayer and Aignostics to collaborate on next generation precision oncology
- Details
- Category: Bayer
AstraZeneca to acquire Amolyt Pharma, expanding late-stage rare disease pipeline
- Details
- Category: AstraZeneca
The proposed acquisition will bolster the Alexion, AstraZeneca Rare Disease late-stage pipeline and expand on its bone metabolism franchise with the notable addition of eneboparatide (AZP-3601), a Phase III investigational therapeutic peptide with a novel mechanism of action designed to meet key therapeutic goals for hypoparathyroidism.
European Commission approves Pfizer's PREVENAR 20® to help protect infants and children against pneumococcal disease
- Details
- Category: Pfizer
Novel molecules from generative AI to Phase II
- Details
- Category: Research
Key protein linked to immune disorders
- Details
- Category: Research
The researchers found that STAP-1 plays an important role in the activation of T cells, which are white blood cells that play a critical role in defending the body against infections and maintaining overall health.
Researchers open new leads in anti-HIV drug development, using a compound found in nature
- Details
- Category: Research
Their results, published March 7 in the Journal of Medicinal Chemistry, offer a new path forward in the development of drugs that could potentially help cure - rather than treat - HIV.
Researchers discover new cancer-fighting role for neutrophils
- Details
- Category: Research
A smart molecule beats the mutation behind most pancreatic cancer
- Details
- Category: Research
UC San Francisco researchers have designed a candidate drug that could help make pancreatic cancer, which is almost always fatal, a treatable, perhaps even curable, condition.
The new molecule permanently modifies a wily cancer-causing mutation, called K-Ras G12D, that is responsible for nearly half of all pancreatic cancer cases and appears in some forms of lung, breast and colon cancer.
Sildenafil (Viagra) as a candidate drug for Alzheimer's disease
- Details
- Category: Research
Sildenafil is the main component of drugs used to treat erectile dysfunction (Viagra) and pulmonary arterial hypertension (Revatio).
Novartis presents new data on safety and efficacy of Zolgensma
- Details
- Category: Novartis